Bristol-Myers CEO: We’re ‘one step closer to creating that great company’ with Celgene

“When the two companies come together, we’ll have two growing businesses,” Caforio said in an interview with “Mad Money’s” Jim Cramer.

“We’re going to be able to launch six new medicines, potentially, in the next two years. It’s going to be a great company, [will] create value for shareholders, [and will be] very good for patients,” he said.